Direkt zum Inhalt
Merck

Bioactive oligosaccharide natural products.

Natural product reports (2014-06-03)
Emilianne K McCranie, Brian O Bachmann
ZUSAMMENFASSUNG

Covering up to December 2013. Oligosaccharide natural products target a wide spectrum of biological processes including disruption of cell wall biosynthesis, interference of bacterial translation, and inhibition of human α-amylase. Correspondingly, oligosaccharides possess the potential for development as treatments of such diverse diseases as bacterial infections and type II diabetes. Despite their potent and selective activities and potential clinical relevance, isolated bioactive secondary metabolic oligosaccharides are less prevalent than other classes of natural products and their biosynthesis has received comparatively less attention. This review highlights the unique modes of action and biosynthesis of four classes of bioactive oligosaccharides: the orthosomycins, moenomycins, saccharomicins, and acarviostatins.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
α-Amylase aus Humanspeichel, Type XIII-A, lyophilized powder, 300-1,500 units/mg protein
Sigma-Aldrich
α-Amylase aus Bacillus sp., Type II-A, lyophilized powder, ≥1,500 units/mg protein (biuret)
Sigma-Aldrich
α-Amylase aus Humanspeichel, Type IX-A, lyophilized powder, 1,000-3,000 units/mg protein
Sigma-Aldrich
α-Amylase aus Bacillus sp., powder, yellow-brown, ~50 U/mg
Sigma-Aldrich
α-Amylase aus Bacillus sp., powder, ≥400 units/mg protein (Lowry)
Sigma-Aldrich
α-Amylase aus Bacillus sp., powder, yellow-brown, ~380 U/mg